HomeRCKT • NASDAQ
add
Rocket Pharmaceuticals Inc
Previous close
$18.43
Day range
$18.37 - $18.89
Year range
$15.98 - $32.45
Market cap
1.71B USD
Avg Volume
1.02M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 73.71M | 7.21% |
Net income | -69.65M | -6.00% |
Net profit margin | — | — |
Earnings per share | -0.74 | 9.76% |
EBITDA | -71.34M | -6.44% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 278.82M | -9.19% |
Total assets | 446.41M | -3.33% |
Total liabilities | 61.78M | 5.04% |
Total equity | 384.64M | — |
Shares outstanding | 90.98M | — |
Price to book | 4.36 | — |
Return on assets | -38.97% | — |
Return on capital | -41.98% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -69.65M | -6.00% |
Cash from operations | -53.82M | -5.81% |
Cash from investing | 55.62M | 78.25% |
Cash from financing | 1.53M | 740.66% |
Net change in cash | 3.33M | 117.10% |
Free cash flow | -29.00M | 5.70% |
About
Founded
1999
Headquarters
Website
Employees
268